Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

UnitedHealth Group Incorporated (UNH)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
548.32+3.10 (+0.57%)
At close: 04:00PM EDT
548.54 +0.22 (+0.04%)
After hours: 07:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close545.22
Open545.50
Bid548.32 x 900
Ask548.55 x 900
Day's Range544.77 - 553.11
52 Week Range383.12 - 553.29
Volume2,257,960
Avg. Volume3,109,714
Market Cap512.889B
Beta (5Y Monthly)0.76
PE Ratio (TTM)28.65
EPS (TTM)19.14
Earnings DateOct 12, 2022 - Oct 17, 2022
Forward Dividend & Yield6.60 (1.21%)
Ex-Dividend DateSep 09, 2022
1y Target Est573.24
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for UNH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • UnitedHealth Group Incorporated
    Weekly Stock ListLast week was the busiest of the quarter for earnings, with many sharp stock-price moves following above- or below-consensus results or changes in guidance. Through July 26, Refinitiv noted that 133 S&P 500 companies had reported earnings, with 76% beating expectations, above the long-term average of 66%. The blended (actual for those reporting and consensus for those still to report) growth rate is 6.2%, near the 5.6% expectation and indicating the "beats" have not been robust. But the sour mood coming into the quarter is being greeted with relief that profit shortfalls and lowered guidance are not rampant. Our analysts always look for companies that boost outlooks during earnings season. Raising guidance can be a catalyst for strong returns in the quarters ahead. Here is an initial list of BUY-rated companies in Argus coverage with raised guidance or increased outlooks during the 2Q22 EPS reporting season.
    Rating
    Fair Value
    Economic Moat
    19 days agoArgus Research
View more
Advertisement
Advertisement